Clinical Trial Update: Open Label Study of DS-5573a [Phase 1]

View source ↗

Summary

Open-label Phase 1 study of DS-5573a by Daiichi Sankyo in patients with advanced solid malignant tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• DS-5573a

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Advanced Solid Malignant Tumors | Phase 1 | Status: TERMINATED